A prospective, randomized clinical trial of universal WBC reduction.
about
Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusionLeukoreduction for the prevention of adverse reactions from allogeneic blood transfusionClinical evidence of blood transfusion effectivenessLeucoreduction of blood components: an effective way to increase blood safety?Clinical effects of reverting from leukoreduced to nonleukoreduced blood in cardiac surgery.Cost-effectiveness of leucoreduction for prevention of febrile non-haemolytic transfusion reactionsRole of Leukoreduction of Packed Red Blood Cell Units in Trauma Patients: A ReviewLeukoreduced blood components: Advantages and strategies for its implementation in developing countries.The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC.Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgeryDecreased sepsis related to indwelling venous access devices coincident with implementation of universal leukoreduction of blood transfusions.Utilization management in the blood transfusion serviceTo filter blood or universal leukoreduction: what is the answer?Red blood cell transfusion in the neurological ICU.Infectious and immunologic consequences of blood transfusionWhat has universal leucodepletion given us: evidence from clinical trials?The top ten list of randomized controlled trials in transfusion medicine.Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill.Transfusion of blood products affects outcome in cardiac surgery.Perioperative transfusion for pancreaticoduodenectomy and its impact on prognosis in resected pancreatic ductal adenocarcinoma.Transfusion immunomodulation--the case for leukoreduced and (perhaps) washed transfusions.Pulmonary complications of transfused blood componentsTransfusion-related acute lung injury in ICU patients admitted with gastrointestinal bleeding.Loss of red cell chemokine scavenging promotes transfusion-related lung inflammation.How important is transfusion avoidance in 2013?Transfusion immunomodulation from a clinical perspective: an update.Red blood cell transfusions for thalassemia: results of a survey assessing current practice and proposal of evidence-based guidelines.Effects of Prestorage Leukoreduction on the Rate of Febrile Nonhemolytic Transfusion Reactions to Red Blood Cells in a Tertiary Care Hospital.Transfusion-related acute lung injury: transfusion, platelets and biological response modifiers.Factors Affecting Tissue Oxygenation in Erythrocyte Transfusions.Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets.Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs.Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction.The abandoned controversy surrounding universal white blood cell reductionWhite-blood-cell-containing allogeneic blood transfusion and postoperative infection or mortality: an updated meta-analysis.Supernatant from stored red blood cell primes inflammatory cells: influence of prestorage white cell reduction.Prolonged platelet storage associated with increased frequency of transfusion-related adverse events.Platelet-white blood cell (WBC) interaction, WBC apoptosis, and procoagulant activity in stored red blood cells.Stored packed red blood cell transfusion up-regulates inflammatory gene expression in circulating leukocytes.Chemokine receptors expressed on T cells in packed red blood cell units change over storage time.
P2860
Q24187243-89448F78-0BFF-4D45-95BC-B9DD3631D89BQ24201602-39BE9130-DFF8-416F-8B65-45501BFE8D26Q24650921-BFD0D0E0-2CFE-4829-968D-D599A451FBECQ26771857-7FC5D909-FFDE-4832-AC0F-76843BBC0009Q33236246-67A15A94-CE13-4CE7-AA61-5F652B5E88B2Q33690883-6656BC94-509C-491B-B04B-17082C7E4569Q33707808-51CEF9BB-5A6F-4F56-9648-01BD3A46867DQ33760699-1ECC498F-FFC1-4C91-A660-F60E7B948F9EQ34285935-285E1FD6-DCAC-4D2B-A42D-548C5F7B95E3Q34362686-EA919310-E3FA-426A-9525-0C017F734E19Q34453403-9051089F-37E8-4785-B4FA-5B20AEF8376AQ35492937-D00941BD-7B2D-4410-AC91-B5EFD3BCBCD7Q35578991-9578DBBD-C170-40D6-981E-B4D374A57881Q35729682-2A348071-0EC4-4FD3-B3C8-E066BCF2115DQ35804510-C02CA80F-7C35-4601-9682-9BBE7640627CQ35813005-88A5E3F2-954D-4A43-93D3-6145ABF37C15Q35813075-CF7C3E59-1E9E-4B3D-9047-8A2E891F7486Q35940036-7DD18AE5-6CB6-4CE5-82ED-58E686B25DE0Q35975696-65012214-FD26-4988-BF75-0EB5108FC2D0Q36408362-25D7D2F1-67DC-437C-86A9-295C366CC796Q36428284-8ECDC107-75BC-412F-B8B9-9AEE621C0688Q37056509-51E68066-B8B6-454F-9623-F58488A7F7A2Q37056527-59D7EEAC-1AD3-454B-BE3E-4061A47B08F0Q37082006-5609A754-8EA5-4C75-9F55-7625BFDD11FEQ38088956-2A617716-5FD4-4634-ACCE-117C4DE46C09Q38156241-EFC1851A-084C-4743-86EC-FA543A660108Q38194595-2057DF87-896D-422B-85DF-4F53A9273C32Q38534070-7E0F700E-335D-44BD-94E3-26D0D3768F40Q38725992-9F3008BE-9A25-4575-A3B1-B388E8B26E6EQ38883048-2EDEA294-B68A-4FD0-A4FC-1BB48071B30DQ40277127-FD2C1AB4-D971-459C-93F6-F0B41814C884Q40543301-45CDD4B6-3107-4AB8-89CD-904F7E79786EQ40543308-A267E1B1-3A9E-45B9-8185-FEC992DF92FEQ42604107-9BCB126B-19C0-4B44-BB24-609E328CFC5FQ43715931-4BF4F78A-20CE-44E7-9224-9A1C0A1057E3Q47712375-77B6D4B1-CD99-46BD-9866-B6CFC0106BE7Q48112813-F2EBF066-5E27-4671-BFAA-5CB09B7E62C2Q50553094-9A05456D-BF51-4F21-B2F1-8108F67FED8BQ50690157-BCAA9689-92EB-49BA-ABC2-E0C120DC38B4Q50726361-4EE9D77B-4692-4400-8807-0E5D072A0264
P2860
A prospective, randomized clinical trial of universal WBC reduction.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
A prospective, randomized clinical trial of universal WBC reduction.
@en
type
label
A prospective, randomized clinical trial of universal WBC reduction.
@en
prefLabel
A prospective, randomized clinical trial of universal WBC reduction.
@en
P2093
P2860
P1433
P1476
A prospective, randomized clinical trial of universal WBC reduction.
@en
P2093
P2860
P304
P356
10.1046/J.1537-2995.2002.00182.X
P577
2002-09-01T00:00:00Z